Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 18, Issue 10

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 18, Issue 10 (2009)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 18, Issue 10 (2009)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Volume 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Article

Phospholipase A2 inhibitors in the treatment of atherosclerosis: a new approach moves forward in the clinic

Keith E Suckling

Pages: 1425-1430

Published online: 20 Aug 2009

AbstractforPhospholipase A2 inhibitors in the treatment of atherosclerosis: a new approach moves forward in the clinic | Full Text | References | PDF (216 KB)

241 Views
15 CrossRef citations
0Altmetric

Discontinued Drugs Perspective

Article

Discontinued psychiatric drugs in 2008

Victoria D Kirchhoff, Ha TT Nguyen, Joanna K Soczynska, Hanna Woldeyohannes & Roger S McIntyre MD FRCPC

Pages: 1431-1443

Published online: 28 Aug 2009

AbstractforDiscontinued psychiatric drugs in 2008 | Full Text | References | PDF (393.6 KB)

211 Views
19 CrossRef citations
0Altmetric

Reviews

Article

Investigational drugs targeting FLT3 for leukemia

Celalettin Ustun MD, David L DeRemer PharmD BCOP, Anand P Jillella MD & Kapil N Bhalla MD

Pages: 1445-1456

Published online: 12 Aug 2009

AbstractforInvestigational drugs targeting FLT3 for leukemia | Full Text | References | PDF (285.3 KB)

149 Views
11 CrossRef citations
0Altmetric

Article

Targeting IL-6 in the treatment of inflammatory and autoimmune diseases

Changhai Ding MD, Flavia Cicuttini PhD, Jun Li MD & Graeme Jones MD

Pages: 1457-1466

Published online: 28 Aug 2009

AbstractforTargeting IL-6 in the treatment of inflammatory and autoimmune diseases | Full Text | References | PDF (278.8 KB)

500 Views
61 CrossRef citations
0Altmetric

Article

Current data of targeted therapies for the treatment of triple-negative advanced breast cancer: empiricism or evidence-based?

Fausto Petrelli, Mary Cabiddu, Mara Ghilardi & Sandro Barni

Pages: 1467-1477

Published online: 08 Sep 2009

AbstractforCurrent data of targeted therapies for the treatment of triple-negative advanced breast cancer: empiricism or evidence-based? | Full Text | References | PDF (279.7 KB)

219 Views
12 CrossRef citations
0Altmetric

Article

Current progress in the pharmacological therapy of fibromyalgia

Srinivas G Rao MD PhD

Pages: 1479-1493

Published online: 07 Sep 2009

AbstractforCurrent progress in the pharmacological therapy of fibromyalgia | Full Text | References | PDF (313.2 KB)

216 Views
13 CrossRef citations
0Altmetric

Article

Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors

Manfredi Rizzo MD PhD, Ali A Rizvi MD, Giatgen A Spinas MD, Giovam Battista Rini MD & Kaspar Berneis MD

Pages: 1495-1503

Published online: 17 Sep 2009

AbstractforGlucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors | Full Text | References | PDF (569.5 KB)

618 Views
67 CrossRef citations
0Altmetric

Article

Emerging oligonucleotide therapies for asthma and chronic obstructive pulmonary disease

Rosanne M Séguin & Nicolay Ferrari

Pages: 1505-1517

Published online: 28 Aug 2009

AbstractforEmerging oligonucleotide therapies for asthma and chronic obstructive pulmonary disease | Full Text | References | PDF (348.1 KB)

440 Views
49 CrossRef citations
0Altmetric

Article

Histamine H₃ and H₄ receptors as novel drug targets

Ekaterini Tiligada PhD, Evangelia Zampeli MD, Kerstin Sander BPharm & Holger Stark PhD

Pages: 1519-1531

Published online: 17 Sep 2009

AbstractforHistamine H₃ and H₄ receptors as novel drug targets | Full Text | References | PDF (392 KB)

997 Views
113 CrossRef citations
0Altmetric

Drug Evaluations

Article

Agomelatine, a melatonin agonist with antidepressant properties

Steven L Dubovsky MD & Calvert Warren MD

Pages: 1533-1540

Published online: 17 Sep 2009

AbstractforAgomelatine, a melatonin agonist with antidepressant properties | Full Text | References | PDF (265.5 KB)

442 Views
31 CrossRef citations
0Altmetric

Article

AVE8062: a new combretastatin derivative vascular disrupting agent

Angelo Delmonte & Cristiana Sessa

Pages: 1541-1548

Published online: 17 Sep 2009

AbstractforAVE8062: a new combretastatin derivative vascular disrupting agent | Full Text | References | PDF (258.9 KB)

393 Views
89 CrossRef citations
0Altmetric

Article

Cediranib: profile of a novel anti-angiogenic agent in patients with glioblastoma

Jörg Dietrich, Daphne Wang & Tracy T Batchelor

Pages: 1549-1557

Published online: 12 Aug 2009

AbstractforCediranib: profile of a novel anti-angiogenic agent in patients with glioblastoma | Full Text | References | PDF (932.7 KB)

158 Views
46 CrossRef citations
0Altmetric

Article

Clofarabine: emerging role in leukemias

Keeran Sampat, Hagop Kantarjian & Gautam Borthakur

Pages: 1559-1564

Published online: 28 Aug 2009

AbstractforClofarabine: emerging role in leukemias | Full Text | References | PDF (246.6 KB)

155 Views
6 CrossRef citations
0Altmetric

Article

Fospropofol disodium, a water-soluble prodrug of the intravenous anesthetic propofol (2,6-diisopropylphenol)

Jörg Fechner MD, Harald Ihmsen PhD, Christian Jeleazcov MD & Jürgen Schüttler MD

Pages: 1565-1571

Published online: 17 Sep 2009

AbstractforFospropofol disodium, a water-soluble prodrug of the intravenous anesthetic propofol (2,6-diisopropylphenol) | Full Text | References | PDF (296.1 KB)

255 Views
16 CrossRef citations
0Altmetric

Article

VEGF Trap-Eye for the treatment of neovascular age-related macular degeneration

James A Dixon MD, Scott CN Oliver MD, Jeffrey L Olson MD & Naresh Mandava MD

Pages: 1573-1580

Published online: 20 Aug 2009

AbstractforVEGF Trap-Eye for the treatment of neovascular age-related macular degeneration | Full Text | References | PDF (263.4 KB)

1720 Views
107 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Investigational drugs for the treatment of acromegaly: new agents to transform therapy

Rosa Pirchio et al.

Review Article | Published online: 30 Apr 2024

Safety, tolerability, and pharmacokinetics of the novel RdRp inhibitor SHEN26 against SARS-CoV-2: a randomized, placebo-controlled, double-blind Phase I study in healthy subjects

Cheng Sun et al.

Article | Published online: 30 Apr 2024

Frontotemporal dementia: from genetics to therapeutic approaches

Francesca R. Buccellato et al.

Review Article | Published online: 30 Apr 2024

Open Access

Drugs in preclinical and early clinical development for the treatment of chagas disease: the current status

Fernanda Karoline Vieira da Silva Torchelsen et al.

Review Article | Published online: 30 Apr 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.18, Iss.10, 2009)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?